---
schema_version: "secwatch.filing_event.v1"
accession: "0000097745-24-000036"
form_type: "8-K"
ticker: "TMO"
cik: "0000097745"
company_name: "THERMO FISHER SCIENTIFIC INC."
filed_at: "2024-07-24T23:59:59+00:00"
generated_at: "2026-05-31T17:44:41.468450+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Thermo Fisher Q2 GAAP EPS $4.04 (+15%), Adj. EPS $5.37 (+4%), raises FY 2024 guidance

## Summary
- Revenue $10.54B, down 1% YoY; organic revenue -1%, core organic revenue flat.
- GAAP operating margin improved to 17.3% from 14.8%; adjusted operating margin 22.3% vs 22.2%.
- Completed Olink acquisition post-quarter to extend proteomics capabilities.
- Raised FY 2024 revenue guidance to $42.4-43.3B (prev. $42.3-43.3B) and adj. EPS to $21.29-22.07 (prev. $21.14-22.02).
- Launched multiple new instruments including Stellar mass spec and biobased bioprocessing film.

## SEC filing metadata
- accession: 0000097745-24-000036
- form_type: 8-K
- ticker: TMO
- cik: 0000097745
- company_name: THERMO FISHER SCIENTIFIC INC.
- filed_at: 2024-07-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/97745/000009774524000036/0000097745-24-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/97745/000009774524000036/tmo-20240724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000097745-24-000036
- JSON: https://secwatch.observer/filing/0000097745-24-000036.json
- Plain text: https://secwatch.observer/filing/0000097745-24-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.